Active Ingredient: TAFENOQUINE SUCCINATE
Proprietary Name: KRINTAFEL
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 150MG BASE
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N210795
Product Number: 001
Approval Date: Jul 20, 2018
Applicant Holder Full Name: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LTD ENGLAND
Marketing Status:
Prescription
Patent and Exclusivity Information
